Source:http://linkedlifedata.com/resource/pubmed/id/10634922
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-6-6
|
pubmed:abstractText |
To determine whether whole body protein kinetics are altered in Duchenne muscular dystrophy (DMD), six 9 +/- 1-year-old children with DMD and five weight and height matched controls, received intravenous infusion of L-[1-(13)C]leucine and L-[2-(15)N]glutamine in the post-absorptive state. Glutamine rate of appearance was approximatly 24% lower in DMD boys than in controls (321 +/- 22 vs 425 +/- 37 micromol kg(-1)h(-1), P< 0.05) resulting from a 32% decrease in glutamine de novo synthesis (230 +/- 21 vs 340 +/- 34 micromol kg(-1)h(-1), P< 0.05). Whereas there was no difference between groups in estimates of protein degradation and synthesis, leucine oxidation rate was 44% higher in DMD boys than in controls (23 +/- 2 vs 16 +/- 2 micromol kg(-1)h(-1), P< 0.05). The data suggest that the dramatic mucle mass loss observed in DMD boys is associated with a) significant protein wasting, since increased leucine oxidation reflects a more negative whole body leucine balance, and b) a significant decrease in glutamine availability in the postabsorptive state. Glutamine might therefore be a 'conditionally essential' amino-acid in DMD.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0261-5614
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 1999 Harcourt Publishers Ltd.
|
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
365-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10634922-Adolescent,
pubmed-meshheading:10634922-Case-Control Studies,
pubmed-meshheading:10634922-Child,
pubmed-meshheading:10634922-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:10634922-Glutamine,
pubmed-meshheading:10634922-Humans,
pubmed-meshheading:10634922-Infusions, Intravenous,
pubmed-meshheading:10634922-Kinetics,
pubmed-meshheading:10634922-Leucine,
pubmed-meshheading:10634922-Male,
pubmed-meshheading:10634922-Muscular Dystrophy, Duchenne,
pubmed-meshheading:10634922-Protein Biosynthesis
|
pubmed:year |
1999
|
pubmed:articleTitle |
Is glutamine a 'conditionally essential' amino acid in Duchenne muscular dystrophy?
|
pubmed:affiliation |
Nemours Children's Clinic, Jacksonville, Florida, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|